Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
20024.0k citationsBertrand Coiffier, Éric Lepage et al.profile →
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
20051.1k citationsCatherine Sebban, Christophe Fermé et al.profile →
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
2001687 citationsÉric Lepage, Jean Le Gall et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Éric Lepage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Lepage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Lepage more than expected).
This network shows the impact of papers produced by Éric Lepage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Lepage. The network helps show where Éric Lepage may publish in the future.
Co-authorship network of co-authors of Éric Lepage
This figure shows the co-authorship network connecting the top 25 collaborators of Éric Lepage.
A scholar is included among the top collaborators of Éric Lepage based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Éric Lepage. Éric Lepage is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Hussain, Sajjad, Nicolas Griffon, Stéfan Darmoni, et al.. (2014). A Semantic Interoperability Framework for Facilitating Cross-Hospital Exchanges.. 1255.1 indexed citations
Carlucci, Annalisa, Jean‐Christophe Richard, Marc Wysocki, Éric Lepage, & Laurent Brochard. (2001). Noninvasive Versus Conventional Mechanical Ventilation. American Journal of Respiratory and Critical Care Medicine. 163(4). 874–880.310 indexed citations
10.
Dosquet, Christine, et al.. (1997). Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?. PubMed. 3(12 Pt 1). 2451–8.127 indexed citations
11.
Bosly, André, Éric Lepage, Bertrand Coiffier, et al.. (1996). Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study. British Journal of Haematology. 93. 546–546.2 indexed citations
Bouhaddou, Omar, Éric Lepage, & Homer R. Warner. (1989). An Approach to Evaluating the Completeness of a Medical Knowledge Base. PubMed Central. 110–115.2 indexed citations
19.
Trédaniel, Jean, Éric Lepage, J Frija, et al.. (1988). [Residual masses after chemotherapy of non-Hodgkin's lymphoma].. PubMed. 30(1-2). 75–7.2 indexed citations
20.
Lepage, Éric, Christophe Fermé, J Frija, et al.. (1984). Maladie de Hodgkin. Masses résiduelles histologiquement non évolutives après chimiothérapie.. La Presse Médicale. 13(29).2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.